Press release
Adult-onset Still Disease (AOSD) market growing at a CAGR of around 7.7%
Adult-onset Still Disease (AOSD) market
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71305
Key Market Drivers
• Increasing awareness and improved identification of AOSD cases.
• Growing use of IL-1 and IL-6 inhibitors as first-line biologic therapies.
• Advances in ferritin and inflammation-marker testing supporting earlier diagnosis.
• Expansion of rheumatology clinics and specialist centers.
Challenges
• High cost of biologic drugs.
• Misdiagnosis due to overlap with other inflammatory diseases.
• Small patient pool limiting large-scale clinical data.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/71305/adult-onset-still-disease-market
Market Segmentation
By Treatment
• Biologics (main revenue generator)
• Non-biologics (corticosteroids, DMARDs)
• Symptomatic therapies
By Diagnosis
• Laboratory tests
• Imaging techniques
• Differential diagnostic evaluations
By End User
• Hospitals
• Specialty rheumatology clinics
• Homecare (for stable patients)
By Distribution Channel
• Retail pharmacies
• Online pharmacies
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71305
Regional Snapshot
• North America leads due to high biologic usage and strong reimbursement.
• Europe shows steady adoption supported by specialty care centers.
• Asia-Pacific is the fastest-growing region due to rising disease recognition and expanding rheumatology infrastructure.
Key Companies
AbbVie, Roche, Novartis, Sanofi, Amgen, Pfizer, GSK, Biogen, UCB, Takeda, Johnson & Johnson.
Future Outlook
The market will continue expanding due to increased biologic adoption, better diagnostic precision, and growing access to specialist care. Personalized medicine and targeted cytokine therapies are expected to define the next decade of AOSD management.
This report is also available in the following languages : Japanese (成人発症スティル疾患市場), Korean (성인 발병 스틸병 시장), Chinese (成人斯蒂尔病市场), French (Marché de la maladie de Still de l'adulte), German (Markt für Still-Krankheit im Erwachsenenalter), and Italian (Mercato della malattia di Still ad esordio nell'adulto), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/71305
Our More Reports:
Oropharyngeal Cancer Market
https://exactitudeconsultancy.com/reports/71260/oropharyngeal-cancer-market
Pancreatic Adenocarcinoma Market
https://exactitudeconsultancy.com/reports/71262/pancreatic-adenocarcinoma-market
Neurofibrosarcoma Market
https://exactitudeconsultancy.com/reports/71264/neurofibrosarcoma-market
Oncolytic Adenovirus Market
https://exactitudeconsultancy.com/reports/71266/oncolytic-adenovirus-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Adult-onset Still Disease (AOSD) market growing at a CAGR of around 7.7% here
News-ID: 4310931 • Views: …
More Releases from Exactitude Consultancy
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250
Key Market Highlights
• Increasing focus on road maintenance and resurfacing projects
• Growing demand for efficient and precision milling…
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248
Key Market Highlights
• Growing adoption of automated credit risk assessment tools
• Increasing focus on working capital and cash flow management
• Integration…
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246
Key Market Highlights
• Growing adoption of VoIP and…
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244
Key Market Highlights
• Rapid growth of…
More Releases for AOSD
Adult-onset Still Disease (AOSD) Market Projected to Grow by 2034 | Cerecor, Roc …
The growth of the Adult-onset Still Disease market is fueled by factors such as rising disease prevalence, increased investment in research and development, and the introduction of innovative therapies during the forecast period from 2020 to 2034.
The market report provides detailed insights into AOSD, including market size and share, epidemiology, emerging treatment options, key drivers and challenges, ongoing clinical trials, strategic collaborations, and therapy adoption by leading companies actively contributing…
Adult-Onset Still's Disease Market to Hit USD 2.5 Billion by 2034
Adult-Onset Still's Disease (AOSD) is a rare systemic autoinflammatory disorder characterized by spiking fevers, arthritis, rash, and elevated inflammatory markers. While its exact cause remains unknown, AOSD is thought to result from dysregulated immune responses involving interleukin (IL)-1, IL-6, and other inflammatory pathways.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71305
Historically, management relied on NSAIDs, corticosteroids, and immunosuppressants, but the past decade has seen major advances with biologic therapies…
Adult-Onset Still Disease Pipeline Insight 2025: IL-1/IL-6 Blockade, JAK Inhibit …
DelveInsight's "Adult-Onset Still Disease - Pipeline Insight, 2025" provides a detailed overview of the evolving therapeutic landscape for this rare systemic autoinflammatory disorder. Traditionally reliant on corticosteroids and conventional DMARDs, Adult-Onset Still Disease (AOSD) has long posed clinical challenges due to its relapsing course, systemic inflammation, and risk of complications such as macrophage activation syndrome.
The 2025 pipeline highlights the growing dominance of targeted biologics, particularly IL-1 and IL-6 inhibitors, which…
Still's Disease Treatment Market Poised for Significant Growth, Driven by Therap …
The Still's disease treatment market is poised for significant growth driven by increasing disease awareness, improved diagnostic capabilities, and the emergence of novel therapeutic options. This growth is fueled by the introduction of innovative biological therapies by key players, including AB2 Bio, Roche, Novartis, Swedish Orphan Biovitrum, Jubilant Life Sciences, Hikma, Teva, and Horizon, among others, which are addressing significant unmet needs in this rare inflammatory condition.
DelveInsight's "Still's Disease -…
Adult-Onset Still Disease Treatment Market Size in 7MM is expected to grow at a …
DelveInsight's "Adult-onset Still's Disease Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of AOSD, historical and forecasted epidemiology, as well as the AOSD market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Unlock key insights into the Adult-onset Still Disease Market! Download DelveInsight's comprehensive report to explore market trends, pipeline analysis, and emerging therapies @ Adult-onset Still…
Adult-onset Still Disease Market Expected to rise by 2034, Cerecor, Roche, Swedi …
The Adult-onset Still Disease market growth is driven by factors like increase in the prevalence of Adult-onset Still Disease, investments in research and development, entry of emerging therapies during the study period 2020-2034.
The Adult-onset Still Disease market report [https://www.delveinsight.com/report-store/adult-onset-still-disease-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr] also offers comprehensive insights into the Adult-onset Still Disease market size, share, Adult-onset Still Disease epidemiology, emerging therapies, market drivers and barriers, ongoing clinical trials, key collaboration in the space, market…
